"Retrospective Comparison of Efficacy and Safety of Basiliximab and Antithymocyte Globulin in Kidney Transplant Recipients" (2021) Khartoum Journal of Pharmaceutical Sciences, 1(1). doi:10.53332/kjps.v1i1.40.